Stephen Gould

Dr. Gould was previously Executive Director, Translational Oncology at Genentech, where he led a team focused on developing tumor specific antibodies weaponized with immune-targeting arms or drug payloads for use in both hematologic and solid tumors. Prior to joining Genentech, Dr. Gould served as Senior Director, Oncology at Curis.

Dr. Gould received his Ph.D. from the University of Connecticut Health Center in Development Biology and held postdoctoral fellowships at the University of California San Francisco in the department of Orthopedic Surgery, and University of Virginia in the Department of Biology.